Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study

The aims of this multicentric retrospective study were to assess in a real-world setting the effectiveness and safety of canagliflozin 100 mg/d (CANA100) as an add-on to the background antihyperglycemic therapy, and to evaluate the intensification of prior sodium–glucose co-transporter type 2 inhibi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Med
Hauptverfasser: Gorgojo-Martínez, Juan J., Gargallo-Fernández, Manuel A., Galdón Sanz-Pastor, Alba, Antón-Bravo, Teresa, Brito-Sanfiel, Miguel, Wong-Cruz, Jaime
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408903/
https://ncbi.nlm.nih.gov/pubmed/32708943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072275
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge